These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 7428302)

  • 1. Plasma high-density lipoprotein metabolism in subjects with primary hypertriglyceridaemia: altered metabolism of apoproteins AI and AII.
    Rao SN; Magill PJ; Miller NE; Lewis B
    Clin Sci (Lond); 1980 Nov; 59(5):359-67. PubMed ID: 7428302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apolipoprotein AI and AII metabolism in patients with primary high-density lipoprotein deficiency associated with familial hypertriglyceridemia.
    Saku K; Gartside PS; Hynd BA; Mendoza SG; Kashyap ML
    Metabolism; 1985 Aug; 34(8):754-64. PubMed ID: 3927110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High density lipoprotein metabolism in a patient with abetalipoproteninemia.
    Illingworth DR; Connor WE; Alaupovic P
    Ann Nutr Metab; 1981; 25(1):1-10. PubMed ID: 6789759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HDL metabolism in HDL deficiency associated with familial hypertriglyceridemia: effect of treatment with gemfibrozil.
    Kashyap ML; Saku K
    Adv Exp Med Biol; 1991; 285():233-6. PubMed ID: 1907081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A DNA polymorphism of an apoprotein gene associates with the hypertriglyceridaemia of primary gout.
    Ferns GA; Lanham J; Dieppe P; Galton DJ
    Hum Genet; 1988 Jan; 78(1):55-9. PubMed ID: 2892776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of action of gemfibrozil on lipoprotein metabolism.
    Saku K; Gartside PS; Hynd BA; Kashyap ML
    J Clin Invest; 1985 May; 75(5):1702-12. PubMed ID: 3923042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relation between the HDL apoproteins and AI isoproteins in subjects with the AIMilano abnormality.
    Franceschini G; Sirtori M; Gianfranceschi G; Sirtori CR
    Metabolism; 1981 May; 30(5):502-9. PubMed ID: 6785551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The metabolism of low density lipoprotein in endogenous hypertriglyceridaemia.
    Sigurdsson G; Nicoll A; Lewis B
    Eur J Clin Invest; 1976 Mar; 6(2):151-8. PubMed ID: 177294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies of the lipid binding characteristics of the apolipoproteins from human high density lipoprotein. II. Calorimetry of the binding of apo AI and apo AII with phospholipids.
    Rosseneu M; Soetewey F; Middelhoff G; Peeters H; Brown WV
    Biochim Biophys Acta; 1976 Jul; 441(1):68-80. PubMed ID: 182250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clofibrate raises plasma apoprotein A-I and HDL-cholesterol concentrations.
    Nestel PJ; Hunt D; Wahlqvist ML
    Atherosclerosis; 1980 Dec; 37(4):625-9. PubMed ID: 7459005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-density lipoprotein apolipoprotein AI and AII turnover in moderate and severe proteinuria.
    Saku K; Mendoza SG; Laver M; Hynd BA; Gartside PS; Kashyap ML
    Nephron; 1988; 50(2):112-5. PubMed ID: 3146703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Turnover of apoproteins A-I and A-II of high density lipoprotein and the relationship to other lipoproteins in normal and hyperlipidemic individuals.
    Fidge N; Nestel P; Ishikawa T; Reardon M; Billington T
    Metabolism; 1980 Jul; 29(7):643-53. PubMed ID: 6770225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-density lipoprotein turnover.
    Nestel PJ
    Am Heart J; 1987 Feb; 113(2 Pt 2):518-21. PubMed ID: 3544764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abnormalities in very low, low and high density lipoproteins in hypertriglyceridemia. Reversal toward normal with bezafibrate treatment.
    Eisenberg S; Gavish D; Oschry Y; Fainaru M; Deckelbaum RJ
    J Clin Invest; 1984 Aug; 74(2):470-82. PubMed ID: 6378975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipoproteins and apoproteins of fetal and newborn piglets.
    Hollanders B; Audé X; Girard-Globa A
    Biol Neonate; 1985; 47(5):270-9. PubMed ID: 4005331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Equilibrium of apoproteins between high density lipoprotein and the aqueous phase: modelling of in vivo metabolism.
    Ponsin G; Pownall HJ
    J Theor Biol; 1985 Jan; 112(1):183-92. PubMed ID: 3974262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HDL sphingomyelin determinations in normal individuals and patients with type IV-hyperlipoproteinaemia.
    Schriewer H; Günnewig V; Assmann G
    J Clin Chem Clin Biochem; 1983 Mar; 21(3):139-43. PubMed ID: 6854224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abnormalities of lipoprotein metabolism in patients with the nephrotic syndrome.
    Joven J; Villabona C; Vilella E; Masana L; Albertí R; Vallés M
    N Engl J Med; 1990 Aug; 323(9):579-84. PubMed ID: 2381443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transport kinetics of plasma free fatty acid, very low density lipoprotein triglycerides and apoprotein in patients with endogenous hypertriglyceridaemia: effects of 2,2-dimethyl, 5(2, 5-xylyoxy) valeric acid therapy.
    Kissebah AH; Alfarsi S; Adams PW; Seed M; Folkard J; Wynn V
    Atherosclerosis; 1976; 24(1-2):199-218. PubMed ID: 182185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitamin E does not influence plasma lipoprotein metabolism in healthy subjects with normal nutritional status.
    Ehnholm C; Huttunen JK; Kostiainen E; Lukka M; Aho K
    Clin Chim Acta; 1982 Jun; 121(3):321-5. PubMed ID: 7105398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.